Search

everythinglearnresearchcommunity

for

Search:↓

ViviScal®, a food supplement, was found to be highly effective in treating hereditary hair loss in young males, while fish extract showed no impact.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Trichotillomania was successfully treated with risperidone and naltrexone.

Valproate can cause hair loss and changes in hair appearance, but may help regrow hair when applied topically.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

The vitamin D receptor helps maintain hair and bone health even without binding vitamin D.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Riboflavin and blue light speed up genipin hair dye, making it fast, glossy, stable, and eco-friendly.

2% Minoxidil does not prevent hair loss during chemotherapy.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Standard nail varnish effectively prevents follicular penetration of certain substances.

Crownvetch seed leachate stunts seedling growth due to toxic compounds.

Liposomes can make the antiandrogen RU 58841 more effective for skin application by reducing absorption, increasing skin retention, and targeting sebaceous structures.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Tofacitinib might be used to treat hair loss.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Ethionine significantly inhibits wool growth in sheep but not hair growth in mice or rats.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.